세계의 신속 미생물 검사 시장 예측(-2029년) : 제품(기기, 시약, 키트), 방법, 용도별
Rapid Microbiology Testing Market by Product (Instruments Reagent, Kits), Method, Application - Global Forecast to 2029
상품코드:1459464
리서치사:MarketsandMarkets
발행일:2024년 04월
페이지 정보:영문 318 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 신속 미생물 검사 시장 규모는 예측 기간 중 10.1%의 CAGR로 추이하며, 2024년 52억 달러에서 2029년에는 83억 달러 규모로 성장할 것으로 예측됩니다.
최근 더 새롭고 빠른 기술의 도입으로 전통적인 미생물 검사에서 신속 검사법으로 점차 전환되고 있습니다. 이러한 기술은 박테리아를 생물학적으로 증폭할 필요가 없으므로 보다 빠르고 효율적으로 검출할 수 있습니다. 미생물 검사는 기존 검사 방법의 한계인 긴 소요 시간과 병원성 균주에 대한 노출을 극복하고 있습니다. 유효성, 효율성, 정확성, 결과의 신속성, 기능성을 향상시키기 위한 지속적인 R&D를 통해 미생물 검사의 기술 발전은 임상 실험실, 병원, 학술기관, 연구실, 제약 및 바이오 기술 기업의 관심을 불러일으키고 있습니다.
조사 범위
조사 대상년
2022-2029년
기준년
2023년
예측 기간
2024-2029년
단위
금액(달러)
부문
제품·방법·용도
대상 지역
북미·유럽·아시아태평양·라틴아메리카·중동 & 아프리카·GCC 국가
제품별로는 시약·키트 부문이 예측 기간 중 가장 높은 성장률을 보일 전망입니다. 이 부문의 성장을 촉진하는 주요 요인으로는 감염성 질환 진단 검사 증가, 다양한 시약에 대한 쉬운 접근성, 보다 신뢰할 수 있고 특이적이며 신속한 초기 미생물 검출에 대한 수요 증가 등이 꼽힙니다.
방법론별로는 핵산 기반 부문이 예측 기간 중 가장 높은 성장률을 보일 것으로 예상됩니다. 이 부문의 빠른 성장은 기술 발전, 더 높은 정확도, 맞춤형 기능의 조합에 기인합니다.
지역별로는 아시아태평양이 가장 빠르게 성장하고 있는 지역입니다. 이 지역의 신흥 국가들은 국내총생산(GDP) 증가와 함께 가처분 소득 수준이 눈에 띄게 증가하고 있습니다. 그 결과, 더 많은 사람들이 의료비 지출이 급증하고 있습니다. 이러한 추세는 많은 환자 인구와 이 지역에 많은 저가형 의료기기 제조업체가 존재하기 때문인 것으로 분석됩니다.
세계의 신속 미생물 검사 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회의 분석, 기술·특허의 동향, 법규제 환경, 시장 규모의 추이·예측, 각종 구분·지역별 상세 분석, 경쟁 구도, 주요 기업의 개요 등을 정리하여 전해드립니다.
목차
제1장 서론
제2장 조사 방법
제3장 주요 요약
제4장 중요 인사이트
제5장 시장 개요
시장 역학
촉진요인
억제요인
기회
과제
가격 분석
특허 분석
밸류체인 분석
공급망 분석
무역 분석
에코시스템 분석
Porter's Five Forces 분석
규제 상황
기술 분석
주요 컨퍼런스와 이벤트
고객의 비즈니스에 영향을 미치는 동향/디스럽션
주요 이해관계자와 구입 기준
투자와 자금조달 시나리오
제6장 신속 미생물 검사 시장 : 제품별
기기
자동 미생물 식별 및 항균제 감수성 시험 시스템
질량 분석계
생물 발광 및 형광 기반 탐지 시스템
PCR 시스템
사이토미터
액티브 에어샘플러
기타
시약·키트
멸균 시약·키트
기타 시약·키트
소모품
제7장 신속 미생물 검사 시장 : 방법별
증식 기반 신속 미생물 검사
세포 성분 기반 신속 미생물 검사
핵산 기반 신속 미생물 검사
생존률 기반 신속 미생물 검사
기타
제8장 신속 미생물 검사 시장 : 용도별
산업 시험
식품 및 음료 검사
의약품·생물제제 검사
환경 시험
화장품·퍼스널케어 제품 검사
기타
임상 질환 진단
연구
제9장 신속 미생물 검사 시장 : 지역별
북미
유럽
아시아태평양
라틴아메리카
중동 및 아프리카
GCC 국가
제10장 경쟁 구도
주요 기업의 채택 어프로치
매출 분배 분석
시장 점유율 분석
기업 평가 매트릭스 : 주요 기업
기업 평가 매트릭스 : 스타트업/중소기업
신속 미생물 검사 벤더의 평가와 재무 지표
브랜드/제품 비교 분석
경쟁 시나리오
제11장 기업 개요
주요 기업
BIOMERIEUX SA
BECTON, DICKINSON AND COMPANY
DANAHER CORPORATION
ABBOTT LABORATORIES
THERMO FISHER SCIENTIFIC INC.
MERCK KGAA
BRUKER
QUIDELORTHO CORPORATION
SARTORIUS AG
CHARLES RIVER LABORATORIES
NEOGEN CORPORATION
기타 기업
DON WHITLEY SCIENTIFIC LIMITED
RAPID MICRO BIOSYSTEMS, INC.
GRADIENTECH
PERKINELMER INC.
RQMICRO AG
COLIFAST AS
SEROSEP LIMITED
BTNX INC.
R-BIOPHARM AG
PARAGON GENOMICS, INC.
KYPHA INC.
VIVIONE BIOSCIENCES
BACTEST LTD.
CORDX
제12장 부록
KSA
영문 목차
영문목차
The rapid microbiology testing market is valued at an estimated USD 5.2 billion in 2024 and is projected to reach USD 8.3 billion by 2029 at a CAGR of 10.1% during the forecast period. There has been a gradual shift from traditional microbiology testing to rapid testing methods in recent years due to the introduction of newer and faster technologies. These technologies eliminate the need for biological amplification of bacteria, making detection quicker and more efficient. Microbial testing has overcome the limitations of long procedural times and exposure to pathogenic strains associated with conventional testing methods. With continuous developments in efficacy, efficiency, accuracy, faster results, and improved functionality, technological advancements in microbiology testing have generated increased interest among clinical laboratories, hospitals, academic institutes, research laboratories, and pharmaceutical & biotechnology companies.
Scope of the Report
Years Considered for the Study
2022-2029
Base Year
2023
Forecast Period
2024-2029
Units Considered
Value (USD) Billion
Segments
Product, method, and application
Regions covered
North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC countries
"Reagents & kits segment accounted for the highest growth rate in the rapid microbiology testing market, by product, during the forecast period."
The rapid microbiology testing market is bifurcated into instruments, reagents & kits, and consumables. The reagents & kits segment in the rapid microbiology testing market is experiencing substantial growth. Major factors driving the growth of this segment include the increasing number of infectious disease diagnostic tests carried out, easy accessibility to a wide range of reagents, and the growing need for more reliable, more specific, and faster detection of microbes in the early stages.
"Nucleic acid-based rapid microbiology testing segment accounted for the highest growth rate in the rapid microbiology testing market, by method, during the forecast period."
The rapid microbiology testing market is bifurcated into growth-based, cellular component-based, nucleic acid-based, viability-based, and other rapid microbiology testing methods based on method. Nucleic acid-based rapid microbiology testing segment is expected to account for the highest CAGR during the forecast period. The rapid growth of this segment is driven by a combination of technological advancements, greater accuracy, and customization capabilities.
"Asia Pacific: The fastest-growing region rapid microbiology testing market."
The worldwide market for rapid microbiology testing is categorized into North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC countries. Notably, the Asia Pacific region is anticipated to experience the most substantial growth in the forecast period. Emerging economies in this geographical area are observing an upswing in their gross domestic products (GDPs) along with a noteworthy increase in disposable income levels. Consequently, there has been a surge in healthcare expenditure among a larger segment of the population. This trend can be attributed to the sizable patient population and the presence of numerous low-cost device manufacturers in the region.
The break-up of the profile of primary participants in the rapid microbiology testing market:
By Company Type: Tier 1 - 40%, Tier 2 - 30%, and Tier 3 - 30%
By Designation: C-level - 27%, D-level - 18%, and Others - 55%
By Region: North America - 51%, Europe - 21%, Asia Pacific - 18%, Latin America - 6%, and Middle East & Africa- 4%
The key players in rapid microbiology testing market are bioMerieux SA (France), Danaher Corporation (US), Becton, Dickinson and Company (US), Abbott Laboratories (US), Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Sartorius AG (Germany), Bruker (US), QuidelOrtho Corporation (US), Charles River Laboratories (US), Neogen Corporation (US), Don Whitley Scientific Limited (UK), Rapid Micro Biosystems, Inc. (US), Gradientech (Sweden), rqmicro AG (Switzerland), Colifast AS (Norway), Serosep Limited (Ireland), Solus PerkinElmer (US), BTNX Inc. (Canada), R-Biopharm AG (Germany), Paragon Genomics, Inc. (US), Kypha Inc. (US), Vivione Biosciences (US), Bactest Ltd. (UK), and CorDx (US).
Research Coverage:
This research report categorizes the rapid microbiology testing market by product (Instruments (automated microbial identification & antimicrobial susceptibility testing systems, mass spectrometers, PCR systems, bioluminescence & fluorescence-based detection systems, cytometers, active air samplers, other instruments), reagents & kits (sterility testing reagents & kits and other reagents & kits), and consumables), by method (Growth-based rapid microbiology testing, cellular component-based rapid microbiology testing, nucleic acid-based rapid microbiology testing, viability-based rapid microbiology testing, and other rapid microbiology testing methods), by application (Clinical disease diagnosis, industrial testing (food & beverage testing, pharmaceutical & biological drug testing, environmental testing, cosmetics & personal care products testing, and other industrial testing applications), and research applications), and region (North America, Europe, Asia Pacific, Latin America, the Middle East & Africa and GCC countries). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, opportunities, and challenges influencing the growth of the rapid microbiology testing market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, key strategies, acquisitions, and agreements. New product & service launches and recent developments associated with the rapid microbiology testing market. Competitive analysis of upcoming startups in the rapid microbiology testing market ecosystem is covered in this report.
Reasons to buy this report:
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall rapid microbiology testing market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, opportunities, and challenges.
The report provides insights on the following pointers:
Analysis of key drivers (Increasing incidence of infectious diseases and cancer, technological advancements in rapid microbiology testing, increased funding for R&D and Increased focus on early detection of infectious diseases), opportunities (Growth opportunities in emerging countries), restraints (High capital investments and low cost-benefit ratio and nfavorable regulatory and reimbursement scenario), and challenges (Operational barriers) influencing the growth of the rapid microbiology testing market.
Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the rapid microbiology testing market.
Market Development: Comprehensive information about lucrative markets - the report analyses the rapid microbiology testing market across varied regions.
Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the rapid microbiology testing market
Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings of leading players like bioMerieux SA (France), Becton, Dickinson and Company (US), Danaher Corporation (US), Abbott Laboratories (US), and Thermo Fisher Scientific Inc. (US).
TABLE OF CONTENTS
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 INCLUSIONS & EXCLUSIONS
1.4 STUDY SCOPE
1.4.1 RAPID MICROBIOLOGY TESTING MARKET
1.4.2 REGIONS COVERED
1.4.3 YEARS CONSIDERED
1.4.4 CURRENCY CONSIDERED
1.5 RESEARCH LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.2 RESEARCH APPROACH
FIGURE 1 RAPID MICROBIOLOGY TESTING MARKET: RESEARCH DESIGN METHODOLOGY
2.2.1 SECONDARY DATA
2.2.1.1 Key data from secondary sources
2.2.2 PRIMARY DATA
2.2.2.1 Primary sources
2.2.2.2 Key data from primary sources
2.2.2.3 Key industry insights
2.2.2.4 Breakdown of primary interviews
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.3 MARKET SIZE ESTIMATION
2.3.1 BOTTOM-UP APPROACH
2.3.1.1 Approach 1: Company revenue estimation approach
FIGURE 4 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
2.3.1.2 Approach 2: Presentations of companies and primary interviews
TABLE 108 RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
TABLE 109 RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 110 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 111 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 112 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 113 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
8.2.1 FOOD & BEVERAGE TESTING
8.2.1.1 Stringent quality control and quality assurance processes to drive market growth
TABLE 114 RAPID MICROBIOLOGY TESTING MARKET FOR FOOD & BEVERAGE TESTING APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
TABLE 115 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR FOOD & BEVERAGE TESTING APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 116 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR FOOD & BEVERAGE TESTING APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 117 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR FOOD & BEVERAGE TESTING APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 118 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR FOOD & BEVERAGE TESTING APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
8.2.2 PHARMACEUTICAL & BIOLOGICAL DRUG TESTING
8.2.2.1 Improved regulatory scenario for drug development to support market growth
TABLE 119 RAPID MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOLOGICAL DRUG TESTING APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
TABLE 120 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOLOGICAL DRUG TESTING APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 121 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOLOGICAL DRUG TESTING APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 122 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOLOGICAL DRUG TESTING APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 123 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOLOGICAL DRUG TESTING APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
8.2.3 ENVIRONMENTAL TESTING
8.2.3.1 Growing focus on environmental monitoring to boost segmental growth
TABLE 124 RAPID MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL TESTING APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
TABLE 125 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL TESTING APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 126 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL TESTING APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 127 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL TESTING APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 128 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL TESTING APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
8.2.4 COSMETICS & PERSONAL CARE PRODUCTS TESTING
8.2.4.1 Growing use of rapid microbiology testing in these industries to determine presence of microbes to favor market growth
TABLE 129 RAPID MICROBIOLOGY TESTING MARKET FOR COSMETICS & PERSONAL CARE PRODUCTS TESTING APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
TABLE 130 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR COSMETICS & PERSONAL CARE PRODUCTS TESTING APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 131 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR COSMETICS & PERSONAL CARE PRODUCTS TESTING APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 132 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR COSMETICS & PERSONAL CARE PRODUCTS TESTING APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 133 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR COSMETICS & PERSONAL CARE PRODUCTS TESTING APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
8.2.5 OTHER INDUSTRIAL TESTING APPLICATIONS
TABLE 134 RAPID MICROBIOLOGY TESTING MARKET FOR OTHER INDUSTRIAL TESTING APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
TABLE 135 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR OTHER INDUSTRIAL TESTING APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 136 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR OTHER INDUSTRIAL TESTING APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 137 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR OTHER INDUSTRIAL TESTING APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 138 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR OTHER INDUSTRIAL TESTING APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
8.3 CLINICAL DISEASE DIAGNOSIS
8.3.1 HIGH BURDEN OF INFECTIOUS DISEASES AND HAIS TO PROPEL MARKET GROWTH
TABLE 139 RAPID MICROBIOLOGY TESTING MARKET FOR CLINICAL DISEASE DIAGNOSIS APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
TABLE 140 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR CLINICAL DISEASE DIAGNOSIS APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 141 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR CLINICAL DISEASE DIAGNOSIS APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 142 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR CLINICAL DISEASE DIAGNOSIS APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 143 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR CLINICAL DISEASE DIAGNOSIS APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
8.4 RESEARCH APPLICATIONS
8.4.1 INCREASING NUMBER OF EPIDEMIOLOGY-BASED RESEARCH STUDIES TO DRIVE MARKET GROWTH
TABLE 144 RAPID MICROBIOLOGY TESTING MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
TABLE 145 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 146 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 147 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 148 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
